Latest Asx News

Page 1088 of 1416
Alterity Therapeutics is set to present compelling Phase 2 clinical trial results for ATH434 at the 2025 International Multiple System Atrophy Congress, highlighting slowed disease progression and biomarker engagement in MSA patients.
Ada Torres
Ada Torres
7 May 2025
Global Data Centre Group updates its distribution guidance following the AirTrunk divestment, factoring in operational costs and risk reserves that temper immediate payouts.
Victor Sage
Victor Sage
7 May 2025
SelfWealth Ltd has officially been acquired by Syfe’s holding company, with shareholders receiving $0.28 per share and the company set to delist from the ASX on May 8.
Claire Turing
Claire Turing
7 May 2025
ARC Funds Limited has secured $1.4 million through equity and debt to complete a strategic acquisition of a majority stake in The Term Deposit Shop, expanding its footprint in Australia's term deposit market.
Claire Turing
Claire Turing
7 May 2025
Tivan Limited’s shares have been suspended at the company’s request pending a major joint venture announcement and its response to an ASX compliance query.
Maxwell Dee
Maxwell Dee
7 May 2025
Mayne Pharma has announced the expiration of the US antitrust waiting period, a critical step forward in Cosette Pharmaceuticals' proposed acquisition. The transaction now moves closer to completion, pending other regulatory and shareholder approvals.
Ada Torres
Ada Torres
7 May 2025
Echo IQ has raised $17.3 million through a strongly supported institutional placement to fund US commercialization and FDA approval efforts for its EchoSolv AI cardiology products.
Ada Torres
Ada Torres
7 May 2025
SciDev Limited reported a robust Q3 FY25 with revenue rising 10% and EBITDA tripling, driven by strategic US market expansion and a landmark PFAS remediation contract despite ongoing market challenges.
Victor Sage
Victor Sage
7 May 2025
Catalina Resources has successfully completed its entitlement and shortfall offer, raising over $2.27 million to strengthen its cash position and advance its diverse mineral projects.
Maxwell Dee
Maxwell Dee
7 May 2025
Prospech Limited reports promising metallurgical test results from its Korsnäs Rare Earth Element resource, highlighting apatite as the dominant and well-liberated mineral. The company is fast-tracking bench-scale concentrate production and hydrometallurgical extraction to advance resource development.
Maxwell Dee
Maxwell Dee
7 May 2025
Althea Group Holdings has agreed to sell its pharmaceutical assets to Tasmanian Botanics, enabling a strategic pivot towards the booming North American THC-infused beverage market.
Victor Sage
Victor Sage
7 May 2025
Adavale Resources has identified a compelling new drill target at its Ashes Prospect through reprocessed geophysical data, supported by high-grade rock chip assays. The company is poised to commence maiden drilling in Q2 2025, aiming to unlock significant gold-copper-silver mineralisation.
Maxwell Dee
Maxwell Dee
7 May 2025